• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Freedom Acquisition I Corp. Cl A filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    12/4/24 4:05:04 PM ET
    $FACT
    Get the next $FACT alert in real time by email
    8-K 1 ea0223510-8k_fact2acq.htm CURRENT REPORT

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): November 27, 2024

     

    FACT II ACQUISITION CORP.

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-42421   N/A
    (State or other jurisdiction of
    incorporation or organization)
      (Commission File Number)   (I.R.S. Employer
    Identification Number)

     

    14 Wall Street, 20th Floor
    New York, New York
    United States of America
      10005
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (212) 618-1798

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one-half of one redeemable warrant   FACTU   Nasdaq Global Market
    Class A ordinary shares, par value $0.0001 per share, included as part of the units   FACT   Nasdaq Global Market
    Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   FACTW   Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 8.01 Other Events.

     

    On November 27, 2024, FACT II Acquisition Corp. (the “Company”) completed (i) its initial public offering (the “IPO”) of 17,500,000 units (the “Units”), at an offering price of $10.00 per Unit, with each Unit consisting of one Class A ordinary share, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one redeemable warrant (the “Public Warrants”), each whole Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment, generating gross proceeds of $175,000,000 (before underwriting discounts and commissions and offering expenses), and (ii) a private placement of an aggregate of 500,625 Private Placement Units (as defined below) at a price of $10.00 per Private Placement Unit and 162,500 Private Placement Securities (as defined below) at a price of $10.00 per Private Placement Security, generating gross proceeds of $6,631,250, as follows: (A) 17,500 private placement units with FACT II Acquisition Parent LLC, with each unit consisting of one Class A Ordinary Share and one-half of one whole warrant to purchase one Class A Ordinary Share at $11.50 per share, subject to adjustment, at a price of $10.00 per unit (the “Private Placement Units”) ($175,000 in the aggregate), (B) (i) 260,000 Private Placement Units ($2,600,000 in the aggregate) with FACT II Acquisition LLC and (ii) 162,500 Private Placement Units and 325,000 restricted Class A Ordinary Shares ($1,625,000 in the aggregate) with FACT II Acquisition LLC, which shares would vest only upon the consummation of an initial business combination (each, a “restricted Class A share”), such restricted shares collectively, the “restricted Class A shares”, the restricted Class A shares together with the Private Placement Units collectively, the “Private Placement Securities”, and two restricted Class A shares together with a Private Placement Unit, each a “Private Placement Security”), at a combined price of $10.00 per Private Placement Security, (C) 178,500 Private Placement Units ($1,785,000 in the aggregate) with Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC, and (D) 44,625 Private Placement Units ($446,250 in the aggregate) with Seaport Global Securities LLC (collectively, the “Private Placement”).

     

    A total of $175,875,000 of the net proceeds from the IPO and the Private Placement (which includes the underwriters’ deferred discount of up to $7,000,000) was placed in a trust account with Odyssey Transfer and Trust Company established for the benefit of the Company’s public shareholders and the underwriters of the IPO. Except for the withdrawal of interest earned on the amounts in the trust account that may be released to the Company to pay its franchise and income tax obligations, or upon the redemption by public shareholders of Class A Ordinary Shares in connection with certain amendments to the Company’s amended and restated memorandum and articles of association, none of the funds held in the trust account will be released until the completion of the Company’s initial business combination or the redemption by the Company of 100% of the outstanding Class A Ordinary Shares issued by the Company in the IPO if the Company does not consummate an initial business combination within 18 months after the closing of the IPO (or 24 months from the closing of the IPO if the Company has executed a definitive agreement for an initial business combination within 18 months from the closing of the IPO) or during any extended time that the Company has to consummate a business combination beyond 18 months from the closing of the IPO (or 24 months from the closing of the IPO if the Company has executed a definitive agreement for an initial business combination within 18 months from the closing of the IPO) as a result of a shareholder vote to amend the Company’s amended and restated memorandum and articles of association, subject to applicable law.

     

    An audited balance sheet as of November 27, 2024 reflecting receipt of the proceeds upon consummation of the IPO and Private Placement has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    99.1 Audited Balance Sheet

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 4, 2024

     

      FACT II ACQUISITION CORP.

     

      By: /s/ Adam Gishen
      Name:  Adam Gishen
      Title: Chief Executive Officer

     

     

    2

     

     

    Get the next $FACT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FACT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FACT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Precision Aerospace & Defense Group Reschedules Investor Day to March 12, 2026

    Precision Aerospace & Defense Group, Inc. ("PAD" or the "Company"), a high-growth aerospace & defense engineering and manufacturing firm, today announced that, due to the winter storm impacting the New York City area, its previously announced Investor Day, originally scheduled for February 25, 2026, has been rescheduled to Thursday, March 12, 2026, beginning at 2:00 p.m. ET and will be held in New York, NY. The Investor Day is being held in connection with the Company's previously announced proposed business combination with FACT II Acquisition Corp. (NASDAQ:FACT). Presentations from PAD's leadership team will cover market dynamics, the Company's business model, strategic priorities, and

    2/24/26 5:40:00 PM ET
    $FACT

    Precision Aerospace & Defense Group to Host Investor Day on February 25, 2026

    Precision Aerospace & Defense Group, Inc. ("PAD" or the "Company"), a high-growth aerospace & defense engineering and manufacturing firm, today announced that it will host an Investor Day on Wednesday, February 25, 2026, beginning at 2:00 p.m. ET in New York, NY. The Investor Day is being held in connection with the Company's previously announced proposed business combination with FACT II Acquisition Corp. (NASDAQ:FACT). Presentations from PAD's leadership team will cover market dynamics, the Company's business model, strategic priorities, and financial profile. A live webcast of the Investor Day will be available on the Company's website at https://padgrp.com/investors/. A copy of the

    2/9/26 4:15:00 PM ET
    $FACT

    Precision Aerospace & Defense Group, Inc. to Combine with FACT II Acquisition Corp. to Become Publicly Listed Company

    Highlights Precision Aerospace & Defense Group, Inc. ("PAD") to merge with FACT II Acquisition Corp. (NASDAQ:FACT) ("FACT"), creating a Nasdaq-listed holistic solutions provider in the aerospace, defense and space industries.PAD's strong growth, platform strengths, blue-chip customer relationships, robust committed backlog and strategic accretive pipeline to provide attractive combination for public market investors.The transaction values PAD at up to a $320 million implied enterprise value (assuming a $10.00 per share price and after giving effect to certain pending acquisitions).PAD has entered into a non-binding indicative term sheet with BC Partners in connection with a potential credit

    12/1/25 4:30:00 PM ET
    $FACT

    $FACT
    SEC Filings

    View All

    SEC Form 425 filed by FACT II Acquisition Corp.

    425 - FACT II Acquisition Corp. (0002028935) (Subject)

    3/25/26 6:35:13 PM ET
    $FACT

    SEC Form 425 filed by FACT II Acquisition Corp.

    425 - FACT II Acquisition Corp. (0002028935) (Subject)

    3/20/26 5:00:56 PM ET
    $FACT

    SEC Form 425 filed by FACT II Acquisition Corp.

    425 - FACT II Acquisition Corp. (0002028935) (Subject)

    3/13/26 9:11:32 PM ET
    $FACT

    $FACT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Fact Ii Acquisition Llc claimed ownership of 440,000 units of Class A ordinary shares (SEC Form 3)

    3/A - FACT II Acquisition Corp. (0002028935) (Issuer)

    2/14/25 4:58:08 PM ET
    $FACT

    SEC Form 3 filed by new insider Fact Ii Acquisition Llc

    3 - FACT II Acquisition Corp. (0002028935) (Issuer)

    11/25/24 9:58:18 PM ET
    $FACT

    SEC Form 3 filed by new insider Rackind Robert

    3 - FACT II Acquisition Corp. (0002028935) (Issuer)

    11/25/24 9:56:28 PM ET
    $FACT

    $FACT
    Leadership Updates

    Live Leadership Updates

    View All

    Complete Solaria Appoints Industry Veteran Brian Wuebbels as Chief Financial Officer

    Complete Solaria, Inc. ("Complete Solaria" or the "Company"), a leading solar technology, services, and installation company, today announced that Brian Wuebbels has been named Chief Financial Officer, effective February 1, 2023. Wuebbels brings more than 20 years of financial and executive experience, having served as CFO and in senior leadership positions for public and private solar and industrial companies throughout his career, including companies such NIDEC, GCL Solar Materials, SunEdison, Honeywell, and General Electric. "I am pleased to welcome Brian to our leadership team," said Will Anderson, Complete Solaria CEO. "Brian's deep and extensive public and private company experience

    2/1/23 8:30:00 AM ET
    $FACT

    Apexigen Announces Appointment of Francis Sarena as Chief Operating Officer

    SAN CARLOS, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced the appointment of Francis Sarena as Chief Operating Officer. Mr. Sarena will be responsible for leading strategic operations, driving business development, overseeing finance and investor relations and optimizing organizational functions. "We are thrilled to welcome Francis, an accomplished industry veteran, during this important phase of Apexigen's evolution," said Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer of Apexigen. "His deep biopharmaceut

    1/4/22 8:00:00 AM ET
    $FACT
    $FPRX
    $PDLI
    Major Pharmaceuticals
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $FACT
    Financials

    Live finance-specific insights

    View All

    Complete Solaria, an Industry-Leading Solar Services, Financing and Products Company, to Publicly List on NYSE through Business Combination with Freedom Acquisition I Corp.

    Complete Solaria has entered into a definitive business combination agreement with Freedom Acquisition I Corp. (NYSE:FACT) ("Freedom"). Upon closing of the business combination, which is expected in the first half of 2023, the combined Company is expected to be listed on the New York Stock Exchange under the new ticker "CSLR". Complete Solaria brings together two highly complementary businesses in a vertically integrated manufacturing and distribution model, delivering end to end residential solar solutions, world-class customer service, aesthetically appealing, high-performance solar panels, as well as project financing, design and software solutions, to the U.S.A and beyond. Complete

    10/3/22 9:09:00 AM ET
    $FACT

    $FACT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Freedom Acquisition I Corp. Cl A (Amendment)

    SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)

    2/14/24 4:05:45 PM ET
    $FACT

    SEC Form SC 13G/A filed by Freedom Acquisition I Corp. Cl A (Amendment)

    SC 13G/A - Complete Solaria, Inc. (0001838987) (Subject)

    2/12/24 1:05:15 PM ET
    $FACT

    SEC Form SC 13G filed by Freedom Acquisition I Corp. Cl A

    SC 13G - Complete Solaria, Inc. (0001838987) (Subject)

    9/22/23 4:22:56 PM ET
    $FACT